{
  "actions": [
    {
      "acted_at": "2020-01-16", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2020-01-16", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr5632-116", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "116", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2020-01-16", 
  "number": "5632", 
  "official_title": "To establish procedures regarding the approval of opioid drugs by the Food and Drug Administration.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s418-116", 
      "identified_by": "CRS", 
      "reason": "identical", 
      "type": "bill"
    }
  ], 
  "short_title": "FDA Accountability for Public Safety Act", 
  "sponsor": {
    "bioguide_id": "K000394", 
    "district": "3", 
    "name": "Kim, Andy", 
    "state": "NJ", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2020-01-16", 
  "subjects": [
    "Congressional oversight", 
    "Department of Health and Human Services", 
    "Drug safety, medical device, and laboratory regulation", 
    "Drug trafficking and controlled substances", 
    "Federal officials", 
    "Food and Drug Administration (FDA)", 
    "Government ethics and transparency, public corruption", 
    "Health", 
    "Marketing and advertising", 
    "Prescription drugs"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "FDA Accountability for Public Safety Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "FDA Accountability for Public Safety Act", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "FDA Accountability for Public Safety Act", 
      "type": "display"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To establish procedures regarding the approval of opioid drugs by the Food and Drug Administration.", 
      "type": "official"
    }
  ], 
  "updated_at": "2020-07-13T18:41:17Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr5632.xml"
}